Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

BACKGROUND: There was still conflict on the antithrombotic advantage of ticagrelor versus clopidogrel among East Asian population with acute coronary syndrome (ACS). We considered that the baseline bleeding risk might be an undetected key factor that significantly affected the efficacy of ticagrelor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, He-Yang, Li, Yi, Xu, Xiao-Ming, Li, Jing, Han, Ya-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111695/
https://www.ncbi.nlm.nih.gov/pubmed/30127210
http://dx.doi.org/10.4103/0366-6999.239306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111695/
https://www.ncbi.nlm.nih.gov/pubmed/30127210
http://dx.doi.org/10.4103/0366-6999.239306

Ejemplares similares